MarginsXMarginsX
Home › Markets › Health Care › ATEC

Alphatec Holdings Inc. (ATEC)

ATEC trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$6.78
-4.10% on the day
Market cap
$1.1B
Small cap
Revenue · 2025
$764.2M
+25.0% on 2024
Net income · 2025
-$143.4M
-18.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1350653/000119312526067393/0001193125-26-067393-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerATEC on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2006
SEC CIK0001350653
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$764.2M
Net income-$143.4M
Operating income-$82.1M
Net margin-18.8%
Operating margin-10.7%
Revenue growth+25.0%
Cash$160.8M
Total assets$791.2M
P/E (computed)Net income was not positive
P/S (computed)1.4×

Warning signs

Cash runway
Cash-flow positive
$79.9M cash at September 30, 2026
Share count, 1 year
+4.4%
2025-10-23 to 2026-10-22 · +13.8% over 3 years
Going-concern doubt
No
10-Q filed October 29, 2026
Insider net buying, 12 months
-$48.2M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-29
Cash and burn$79.9M cash; operating cash flow $15.3M a quarter.Report 2026-09-30
Shares outstanding155,139,824 (2026-10-22); 148,550,185 a year earlier; 136,300,664 three years earlier.Cover page 2026-10-22
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, San Diego, California, United StatesPCAOB Form AP 2026-03-03
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $2.0M, sold $50.2M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$221.2M-$5.5M$18.9M$79.9M$552.3M$839.7M10-Q 2026-10-29
Q2 2026
2026-06-30
$213.5M-$25.8M$20.5M$118.7M$640.8M$815.1M10-Q 2026-08-04
Q1 2026
2026-03-31
$192.1M-$33.9M$1.3M$139.9M$638.9M$787.1M10-Q 2026-05-05
Q4 2025
2025-12-31
$212.9M-$21.7M$20.7M$160.8M$630.5M$764.2M10-K 2026-02-24
Q3 2025
2025-09-30
$196.5M-$28.6M$14.0M$155.7M$624.3M$728.0M10-Q 2026-10-29
Q2 2025
2025-06-30
$185.5M-$41.1M$15.5M$157.1M$555.8M$682.2M10-Q 2026-08-04
Q1 2025
2025-03-31
$169.2M-$51.9M-$5.0M$153.2M$551.0M$642.3M10-Q 2026-05-05
Q4 2024
2024-12-31
$176.8M-$33.3M$10.5M$138.8M$577.8M$611.6M10-K 2026-02-24

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2024-11-15
Latest annual report10-K2026-02-24
Latest quarterly / interim10-Q2026-10-29
Latest current report8-K2026-10-29
Latest proxyDEFA14A2026-04-29

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-5.0%
1 month-34.7%
3 months-27.5%
Year to date-66.4%
1 year-65.0%
From 52-week high-68.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
SIBNSI-BONE Inc.$23.41-0.13%$1.1B
SGPSpyGlass Pharma Inc.$32.24-1.95%$1.1B
IRMDiRadimed Corporation$84.84-0.60%$1.1B
IARTIntegra LifeSciences Holdings Corporation$13.98-2.92%$1.1B
DRTSAlpha Tau Medical Ltd.$11.97-10.54%$1.1B
AORTArtivion Inc.$18.47-3.30%$901.1M
BVSBioventus Inc.$10.46-1.88%$881.4M
TNDMTandem Diabetes Care Inc.$18.48-7.92%$1.3B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier